| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |